MediWound (MDWD) Short-Term Debt issuances (2013)
MediWound (MDWD) recorded quarterly Short-Term Debt issuances of $2.5 million in Q2 2013, up 71.97% quarter-over-quarter from $1.4 million in Q1 2013.
MediWound (MDWD) Short-Term Debt issuances (2013) Analysis & Trends
MediWound's Short-Term Debt issuances history runs 1 years deep, the most recent figure standing at $2.5 million for Q2 2013.
- In Q2 2013, Short-Term Debt issuances changed N/A year-over-year to $2.5 million; the TTM figure through Dec 2013 stood at $3.9 million (changed N/A YoY), while the FY2013 annual figure was $3.9 million, changed N/A from the prior year.
- Short-Term Debt issuances was $2.5 million for Q2 2013 at MediWound, up from $1.4 million in the prior quarter.
- In the past five years, Short-Term Debt issuances ranged from a high of $2.5 million in Q2 2013 to a low of $1.4 million in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ST Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -33,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 2.49 Mn |
| Jun 30, 2013 | 2.49 Mn |
| Mar 31, 2013 | 1.45 Mn |
| Mar 31, 2013 | 1.45 Mn |